NexgenRx Inc.
NEGXF
$0.19
$0.002.55%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 291.41% | 996.57% | 7.43% | 93.09% | 212.21% |
| Total Depreciation and Amortization | 0.18% | -0.89% | -7.48% | 11.55% | -5.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -9.14% | -- |
| Total Other Non-Cash Items | 66.96% | -172.33% | -26.76% | 336.55% | -539.62% |
| Change in Net Operating Assets | 97.62% | -41.63% | 65.53% | -229.64% | -153.82% |
| Cash from Operations | 594.35% | 0.94% | 162.92% | -41.12% | -82.57% |
| Capital Expenditure | 51.79% | -729.78% | -72.99% | -136.78% | 85.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.16% | 6.62% | -37.50% | -- | -- |
| Cash from Investing | 41.11% | -136.00% | -48.33% | -2,198.85% | -72.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.68% | -41.08% | -64.25% | -13.55% | -53.18% |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1,065.70% | 0.85% | 6.12% | 76.34% | 1.63% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13,877.27% | -1.50% | -188.28% | 78.22% | -75.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,052.14% | -47.41% | 134.61% | -123.15% | -94.84% |